YF135, a reversible-covalent KRAS G12C PROTAC, effectively induces the degradation of KRAS G12C and reduces phospho-ERK levels via the E3 ligase VHL-mediated proteasome pathway. Designed by integrating the KRAS G12C inhibitor 48 (compound 6d) as the ligand, YF135 utilizes the MRTX849 linkage VHL ligand scaffold.
Molekulargewicht:
1179.86
CAS Nummer:
[2913177-53-2]
Formel:
C63H75ClN12O7S
Target-Kategorie:
ERK|||Ras|||PROTACs|||Kras
T74336
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
